Casodex vs Placebo in Non-Metastatic Early Prostate Cancer

Clinical trial NCT00672282 · COMPLETED

Trial details

NCT number: NCT00672282
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Metastatic Prostate Cancer

Start date: 1995-10-01
Enrollment: 1218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.